Molecular Basis of Cardiovascular Diseases: Implications of Natriuretic Peptides

The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and...

Full description

Saved in:
Bibliographic Details
Main Author: Rubattu, Speranza (auth)
Other Authors: Volpe, Massimo (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_53824
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2019 xx |||||o ||| 0|eng d
020 |a books978-3-03921-583-6 
020 |a 9783039215836 
020 |a 9783039215829 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03921-583-6  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Rubattu, Speranza  |4 auth 
700 1 |a Volpe, Massimo  |4 auth 
245 1 0 |a Molecular Basis of Cardiovascular Diseases: Implications of Natriuretic Peptides 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (212 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and kidney functions. NPs have also been implicated in the pathogenesis of several cardiovascular diseases (CVDs), including hypertension, atherosclerosis, heart failure, and stroke. A fine comprehension of the molecular mechanisms dependent from NPs and underlying the promotion of cardiovascular damage has contributed to improve our understanding of the molecular basis of all major CVDs. Finally, the opportunity to target NPs in order to develop new therapeutic tools for a better treatment of CVDs has been developed over the years. The current Special Issue of the Journal covers all major aspects of the molecular implications of NPs in physiology and pathology of the cardiovascular system, including NP-based therapeutic approaches. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a postmortem biochemistry 
653 |a medulla 
653 |a animal models 
653 |a remodeling 
653 |a BNP 
653 |a PCSK9 
653 |a guanylyl cyclase/natriuretic peptide receptor-A 
653 |a cardiorenal syndrome 
653 |a forensic medicine 
653 |a preserved ejection fraction 
653 |a kidney 
653 |a renin-angiotensin-aldosterone system 
653 |a atrial fibrillation 
653 |a vasopressor 
653 |a congestive heart failure 
653 |a atrial natriuretic peptide 
653 |a gene-knockout 
653 |a obesity 
653 |a heart failure 
653 |a angiogenesis 
653 |a adipose tissue 
653 |a vascular 
653 |a LDL receptor 
653 |a metabolic syndrome 
653 |a linkage analysis 
653 |a cardiometabolic disease 
653 |a cardiomyocyte 
653 |a cardiac dysfunction 
653 |a cardiac hypertrophy 
653 |a insulin 
653 |a lipid metabolism 
653 |a cGMP 
653 |a Idiopathic Pulmonary Arterial Hypertension (IPAH) 
653 |a Natriuretic Peptide Clearance Receptor (NPR-C) signaling 
653 |a gene-duplication 
653 |a renin-angiotensin system 
653 |a natriuretic peptides 
653 |a angiotensin receptor-neprilysin inhibitor 
653 |a cardiac remodelling 
653 |a ARNi 
653 |a NT-proBNP 
653 |a inflammation 
653 |a pulmonary arterial hypertension 
653 |a vascular homeostasis 
653 |a endothelial cell 
653 |a Atrial Natriuretic peptide 
653 |a natriuretic peptide 
653 |a vasodilator 
653 |a stroke 
653 |a genetic variants 
653 |a arterial hypertension 
653 |a fibroblast 
653 |a MANP 
653 |a hypertension 
653 |a guanylyl cyclase receptor A 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1733  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/53824  |7 0  |z DOAB: description of the publication